MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo

被引:329
作者
Liu, Bo [1 ]
Peng, Xiao-Chun [2 ]
Zheng, Xiao-Li [3 ]
Wang, Jun [4 ]
Qin, Yong-Wen [1 ]
机构
[1] ChangHai Hosp, Cardiovasc Dept, Shanghai 200433, Peoples R China
[2] Shanghai Sixth Peoples Hosp, Dept Orthopaed, Shanghai, Peoples R China
[3] Second Mil Med Univ, Sch Pharm, Dept Pharmaceut, Shanghai, Peoples R China
[4] Second Mil Med Univ, Sch Pharm, Dept Pharmacol, Shanghai, Peoples R China
关键词
Lung cancer; miR-126; Vascular endothelial growth factor; Gene therapy; PROGNOSTIC VALUE; MICRORNAS; EXPRESSION; BEVACIZUMAB; CARBOPLATIN; PACLITAXEL; RECEPTORS; FLT-1;
D O I
10.1016/j.lungcan.2009.01.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Vascular endothelial growth factor (VEGF) is a positive regulator of angiogenesis, and its expression is up-regulated in manycarcinomas. In the present study, we found that a microRNA miR-126 has a binding site in 3'-untranslated region of the VEGF-A mRNA. In eight lung cancer cell lines, expression of miR-126 was down-regulated. Reporter gene assay showed that the co-transfection of mir-126 expression vector with pLuc-VEGF/mir126BS could reduce the activity of luciferase. Transfection experiments showed that miR-126 could decrease the expression of VEGF-A. Three human lung carcinoma cell lines A549, Y-90 and SPC-A1 were investigated as cancer models in vitro, and A549 infected by lentivirus-miR-126 (LV-miR-126) was studied in tumor xenograft model. Infection of LV-miR-126 can down-regulate the expression of VEGF-A in A549, Y-90 and SPC-A1 cell lines and can inhibit the growth of these cells. In addition, flow cytometry analysis revealed that LV-miR-126 infection can induce cell cycle G1 arrest in A549, Y-90 and SPC-A1 cells. Furthermore, in nude mice, the average weight of A549 tumor nodules in experimental group was reduced from 0.8035 +/- 0.1521 to 0.6235 +/- 0.0757 g, with the inhibitive rate being 22.4%. All these results revealed that miR-126 may have a tumor suppressor function in lung cancer cells and could be a promising treatment in anticancer therapy. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:169 / 175
页数:7
相关论文
共 21 条
[11]   Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets [J].
Lewis, BP ;
Burge, CB ;
Bartel, DP .
CELL, 2005, 120 (01) :15-20
[12]  
MASSIMO N, 2008, BREAST CANCER RES, V10, P203
[13]   Microarray analysis of microRNA expression in the developing mammalian brain [J].
Miska, EA ;
Alvarez-Saavedra, E ;
Townsend, M ;
Yoshii, A ;
Sestan, N ;
Rakic, P ;
Constantine-Paton, M ;
Horvitz, HR .
GENOME BIOLOGY, 2004, 5 (09)
[14]  
Nishi M, 2005, INT J ONCOL, V26, P1517
[15]   Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer [J].
Sandler, Alan ;
Gray, Robert ;
Perry, Michael C. ;
Brahmer, Julie ;
Schiller, Joan H. ;
Dowlati, Afshin ;
Lilenbaum, Rogerio ;
Johnson, David H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (24) :2542-2550
[16]   Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer [J].
Seto, T ;
Higashiyama, M ;
Funai, H ;
Imamura, F ;
Uematsu, K ;
Seki, N ;
Eguchi, K ;
Yamanaka, T ;
Ichinose, Y .
LUNG CANCER, 2006, 53 (01) :91-96
[17]  
Volm M, 1997, INT J CANCER, V74, P64, DOI 10.1002/(SICI)1097-0215(19970220)74:1<64::AID-IJC11>3.0.CO
[18]  
2-I
[19]  
Volm M, 1997, ANTICANCER RES, V17, P99
[20]   Aberrant Expression of Oncogenic and Tumor-Suppressive MicroRNAs in Cervical Cancer Is Required for Cancer Cell Growth [J].
Wang, Xiaohong ;
Tang, Shuang ;
Le, Shu-Yun ;
Lu, Robert ;
Rader, Janet S. ;
Meyers, Craig ;
Zheng, Zhi-Ming .
PLOS ONE, 2008, 3 (07)